Thallion's share price rises on buyout interest
This article was originally published in Scrip
Executive Summary
Thallion Pharmaceuticals is pondering its options after an unnamed pharmaceutical company expressed an interest in acquiring the Canadian firm. The news pushed Thallion's share price up from $0.10 to $0.20 at the close of trading yesterday.